Authors/Disclosures
|
Joseph Sebastian, MD
(Caritas Hospital)
|
No disclosure on file |
|
Marie Beaudin, MD
|
Dr. Beaudin has nothing to disclose. |
|
Brenna Derksen
|
No disclosure on file |
|
|
No disclosure on file |
|
Georgios Tsivgoulis, MD, FAAN
(NEURODIAGNOSTICS AND NEUROTHERAPEUTICS PC)
|
Dr. Tsivgoulis has nothing to disclose. |
|
Hamza I. Maqsood, MD
(Dept of Neurology)
|
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
|
Andrei V. Alexandrov, MD
(Department of Neurology, UTHSC)
|
The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care. |
|
Vijay K. Sharma, MD
|
No disclosure on file |
|
Ken Uchino, MD
(Cleveland Clinic Foundation)
|
Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH. |
|
Andrew M. Demchuk, MD
(Foothills Hospital/Calgary Stroke Program)
|
Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care. |
|
Ashfaq Shuaib, MD
(Div of Neurology)
|
Dr. Shuaib has nothing to disclose. |
|
Maher Saqqur, MD
(University of Alberta)
|
Dr. Saqqur has nothing to disclose. |